NucleusX Market Access is the partner of choice in market/payer access strategy, value demonstration, decision support, and launch preparation/implementation. Whether you're in early-stage development or six months from launch, our global market/payer access & HEOR commercialization team has experience to help you determine key stakeholder requirements, gather actionable data, and deliver a compelling story to your customers.

Capitalizing on Nucleus Global’s more than 30 years of experience in transforming raw science into commercial reality, NucleusX Market Access projects are supported by highly credentialed scientists, health economists, payer & reimbursement specialists, marketing experts, healthcare professionals, and medical writers strategically placed around the globe. Additionally, internal teams with expertise in digital media, project management, publication planning, graphic design, and travel/event planning help to fully integrate NucleusX Market Access analysis and strategy into global evidence development and communications programs.

Specializing in informed market/payer access and reimbursement, including primary and secondary market research & analytics and customized solutions in areas such as global brand/market strategy, advisory boards/Mock P&T meetings (live & virtual), pull-through strategies, pricing and contracting strategies, segmentation, specialty drug access, specialty distribution, emerging/growth markets & healthcare reform (e.g. Health Insurance Exchanges, ACOs, Medicaid expansion, Employers, 340B Program, etc.). HEOR offerings include HECON, HIT and HTA/AMCP Dossier, HEOR manuscript preparation and publication planning, message testing, value proposition, new product development/assessment, and HUB strategies, in all phases of the product lifecycle.

View NucleusX Market Access Brochure